CYTOFIND DIAGNOSTICS
Cytofind Diagnostics is developing unique technology in the field of oncology diagnostics, aimed at improving outcomes, improving quality of life and reducing cost in oncology care
CYTOFIND DIAGNOSTICS
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Life Science Medical Medical Device
Founded:
2014-01-01
Address:
Amsterdam, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.cytofind.com
Total Employee:
1+
Status:
Active
Total Funding:
50 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Shutterstock Wordpress 4.9 SiteOrigin Panels
Similar Organizations
CardioGenics
CardioGenics develops sensitive diagnostic test products to the IVD market.
Genomill Health
We are a precision diagnostics company with a mission to disrupt the use of molecular diagnostic tests - liquid biopsies and beyond.
LEX Diagnostics
LEX Diagnostics is a medical device company that specializes in molecular diagnostics for primary care.
Metabolomic Diagnostics
Metabolomic Diagnostics specializes in the development of novel biomarker based diagnostic solutions for complex diseases
PoroUS
PoroUS combines 3D ultrasound technology and image guidance with sophisticated spectral signal processing to ensure osteoporosis diagnoses.
Qubiotech
Qubiotech is developing a full ecosystem of computer aided diagnostic applications called NEUROCLOUD.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Cytofind Diagnostics
Official Site Inspections
http://www.cytofind.com
- Host name: mxd3.aruba.it
- IP address: 62.149.128.166
- Location: Arezzo Italy
- Latitude: 43.4631
- Longitude: 11.8783
- Timezone: Europe/Rome
- Postal: 52100
More informations about "Cytofind Diagnostics"
Cytofind – enabling CTC analyses
Cytofind in peer reviewed journals: Del Ben, F. et al. Preliminary clinical results of a metabolism-based method to detect circulating tumor cells. European Journal of Cancer 72, S150 (2017). …See details»
Cytofind Diagnostics - Crunchbase Company Profile & Funding
Organization. Cytofind Diagnostics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Cytofind Diagnostics is developing unique …See details»
Cytofind - Company Profile - Tracxn
3 days ago What are the most recent funding rounds of Cytofind? Its latest funding round was a Grant (prize money) round on Dec 31, 2016 for $52.7K. 1 investor participated in its latest …See details»
Cytofind Diagnostics - Craft
See insights on Cytofind Diagnostics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
CYTOFIND DIAGNOSTICS BV - VentureRadar
"Cytofind Diagnostics aims to bring to market a proprietary CTC detection method based on a combination of a highly innovative picodroplet-based microfluidic technology for single cell …See details»
Cytofind - Founders and Board of Directors - Tracxn
Aug 3, 2024 Cytofind's founder is Wilhelm Huck. Yobro Studios-Laval based, 2020 founded, Unfunded company; Incontact-Ukraine based, 2021 founded, Unfunded company; Jaunas …See details»
Cytofind Diagnostics - Funding, Financials, Valuation & Investors
Cytofind Diagnostics develops unique technology in the field of oncology diagnostics to improve outcomes & quality of life. Search Crunchbase. ... How much funding has this organization …See details»
Cytofind Diagnostics - Tech Stack, Apps, Patents & Trademarks
Cytofind Diagnostics develops unique technology in the field of oncology diagnostics to improve outcomes & quality of life.See details»
Cytofind Diagnostics: Circulating Tumor Cell Detection and ... - NWO
Jan 1, 2017 Cytofind Diagnostics is developing a unique approach for enumeration and extraction of living Circulating Tumor Cells (CTCs) from blood samples. It is the first method to …See details»
Cytofind - Raised Funding from 1 investor - Tracxn
Oct 31, 2024 Cytofind raised $52.7K in its latest funding round, which was Grant (prize money) round held on Dec 31, 2016. How much funding has Cytofind raised till date? Cytofind has …See details»
FIND | Diagnosis for all
Nov 11, 2024 FIND accelerates equitable access to reliable diagnosis around the world. We are working to close critical testing gaps that leave people at risk from preventable and treatable …See details»
Cellular Analytics - VentureRadar
At Cellular Analytics, we are deploying a proven and proprietary microfluidic platform (CytoFind™) optimized for the detection of rare cells. Cellular Analytics' proprietary microfluidic platform …See details»
Circulating Tumor Cell Collection, Analysis Methods Make
Jan 7, 2020 In November, University of Toronto researchers launched a startup called Cellular Analytics to commercialize a microfluidic CTC capture platform called "Cytofind" that …See details»
Cellular Analytics Eyes Drug Development Space with
Nov 6, 2019 Kelley explained that CytoFind, which relies on single-cell mRNA cytometry, uses about 3 ml of a blood sample and applies two classes of magnetic particles labeled to …See details»
Detection of Rare Circulating C Biomarkers using M - University of …
Figure 2.3 Determining sensitivity, specificity, and viability of cells using CytoFind technology. Figure 2.4 Molecular profiling through CytoFind technology. Figure 2.5 Analytical Validation of …See details»
Cytofind Diagnostics - Crunchbase
Cytofind Diagnostics develops unique technology in the field of oncology diagnostics to improve outcomes & quality of life.See details»
High-potency TIL cell therapy approach reported using CytoFind …
January 27, 2022 - January 27, 2022 – FACIT congratulates portfolio company Cellular Analytics on a recent publication by its CSO, Dr. Shana Kelley and collaborators, on the Company’s …See details»
A liquid biopsy for detecting circulating mesothelial precursor cells ...
Oct 9, 2020 Fluorescent intensity measurements for mesothelin expression in each zone of the CytoFind device. All fluorescent measurements were averaged from 10 randomly selected …See details»
New approach to fertility preservation offers young cancer …
20 hours ago Kelly Wilson Cull, director of advocacy for the Canadian Cancer Society, said her organization is urging provincial and territorial governments to publicly fund ovarian tissue …See details»
Probing single-cell metabolism reveals prognostic value of highly ...
Despite their important role in metastatic disease, no general method to detect circulating stromal cells (CStCs) exists. Here, we present the Metabolic Assay-Chip (MA-Chip) as a label-free, …See details»